These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6974498)

  • 1. Menopausal status associated with increased inhibition of blood coagulation.
    Notelovitz M; Kitchens CS; Rappaport V; Coone L; Dougherty M
    Am J Obstet Gynecol; 1981 Sep; 141(2):149-52. PubMed ID: 6974498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of low-dose oral contraceptives on coagulation and fibrinolysis in two high-risk populations: young female smokers and older premenopausal women.
    Notelovitz M; Levenson I; McKenzie L; Lane D; Kitchens CS
    Am J Obstet Gynecol; 1985 Aug; 152(8):995-1000. PubMed ID: 4025463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulative and fibrinolytic studies on postmenopausal women treated with a new non-steroidal oestrogen.
    Kullander S; Svanberg L; Astedt B
    Acta Obstet Gynecol Scand; 1977; 56(4):371-4. PubMed ID: 74933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation, oestrogen and the menopause.
    Notelovitz M
    Clin Obstet Gynaecol; 1977 Apr; 4(1):107-28. PubMed ID: 140032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. fibrinolysis=fibronolysis.
    Mitchell GA
    Semin Thromb Hemost; 1983 Oct; 9(4):268-80. PubMed ID: 6362010
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.
    Notelovitz M; Kitchens C; Ware M; Hirschberg K; Coone L
    Obstet Gynecol; 1983 Nov; 62(5):596-600. PubMed ID: 6621949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation and fibrinolysis in thyroid disease.
    Rennie JA; Bewsher PD; Murchison LE; Ogston D
    Acta Haematol; 1978; 59(3):171-7. PubMed ID: 416638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis.
    Sundqvist SB; Hedner U; Kullenberg HK; Bergentz SE
    Br Med J (Clin Res Ed); 1981 Jul; 283(6286):265-7. PubMed ID: 6788281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J; Petersen KR; Skouby SO
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.